Small Molecule Efflux Pump Inhibitors in Mycobacterium tuberculosis: A Rational Drug Design Perspective-Reference-Cited by-同舟云学术

Small Molecule Efflux Pump Inhibitors in Mycobacterium tuberculosis: A Rational Drug Design Perspective

Published:2017-12-08 Issue:1 Volume:18 Page:
ISSN:1389-5575
Container-title:Mini-Reviews in Medicinal Chemistry
language:en
Short-container-title:MRMC

Author:

Kapp Erika¹,Malan Sarel F.¹,Joubert Jacques¹,Sampson Samantha L.²

Affiliation:

1. University of the Western Cape, School of Pharmacy Bellville, Bellville, South Africa

2. University of Stellenbosh, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences Bellville, Bellville, Western Cape, South Africa

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology,General Medicine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Resistant Tuberculosis: Development Mechanisms and Methods of Molecular Genetic Diagnosis;Annals of the Russian academy of medical sciences;2024-02-29

2. A novel major facilitator superfamily-type tripartite efflux system CprABC mediates resistance to polymyxins in Chryseobacterium sp. PL22-22A;Frontiers in Microbiology;2024-02-23

3. Phytocompounds as potential inhibitors of mycobacterial multidrug efflux pump Rv1258c: an in silico approach;AMB Express;2024-02-15

4. Protein targets in Mycobacterium tuberculosis and their inhibitors for therapeutic implications: A narrative review;International Journal of Biological Macromolecules;2023-07

5. Design and synthesis of benzochromene derivatives as AcrB inhibitors for the reversal of bacterial multidrug resistance;European Journal of Medicinal Chemistry;2023-03